![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
![Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances](https://www.science.org/cms/10.1126/sciadv.aax9115/asset/444fb070-f156-49ca-bb7a-06de580c94d4/assets/graphic/aax9115-f1.jpeg)
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
![Table 1 from Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors | Semantic Scholar Table 1 from Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3ee6606b27751656285b7108eac6a5e8030e0439/4-Table1-1.png)
Table 1 from Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors | Semantic Scholar
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig1_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g004.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Chemical structures of 'affinity-dominant' and 'efficacy-dominant' G... | Download Scientific Diagram Chemical structures of 'affinity-dominant' and 'efficacy-dominant' G... | Download Scientific Diagram](https://www.researchgate.net/profile/Richard-Van-Rijn/publication/332467705/figure/fig2/AS:748672023293953@1555508728151/Chemical-structures-of-affinity-dominant-and-efficacy-dominant-G-protein-biased-k_Q320.jpg)
Chemical structures of 'affinity-dominant' and 'efficacy-dominant' G... | Download Scientific Diagram
![Molecules | Free Full-Text | Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction Molecules | Free Full-Text | Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction](https://pub.mdpi-res.com/molecules/molecules-27-05826/article_deploy/html/images/molecules-27-05826-ag.png?1663047608)
Molecules | Free Full-Text | Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction
![Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00214/article_deploy/html/images/pharmaceuticals-15-00214-g001.png)
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
![Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep30797/MediaObjects/41598_2016_Article_BFsrep30797_Fig1_HTML.jpg)
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
![Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects](https://pub.mdpi-res.com/molecules/molecules-28-00346/article_deploy/html/images/molecules-28-00346-g007.png?1672561695)